H. R. 9021 proposes an amendment to the Internal Revenue Code of 1986 that would prevent companies from deducting expenses related to direct-to-consumer advertising of prescription drugs from their taxes. This means that businesses will no longer receive a tax break for money...
Simple Explanation
H. R. 9021 is a proposed rule that would stop drug companies from getting a tax discount for showing ads on TV or the internet to sell their medicines. This means they might spend less money on commercials, and people might see fewer ads about medicines.